<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2D8E82C0-85D1-4809-90FC-4716F4AF5865"><gtr:id>2D8E82C0-85D1-4809-90FC-4716F4AF5865</gtr:id><gtr:name>Institute of Food Research</gtr:name><gtr:department>Contracts</gtr:department><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:postCode>NR4 7UA</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2D8E82C0-85D1-4809-90FC-4716F4AF5865"><gtr:id>2D8E82C0-85D1-4809-90FC-4716F4AF5865</gtr:id><gtr:name>Institute of Food Research</gtr:name><gtr:address><gtr:line1>Norwich Research Park</gtr:line1><gtr:line2>Colney</gtr:line2><gtr:postCode>NR4 7UA</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/952D1F1D-C80F-4C12-8AB8-A02FD76BF1C1"><gtr:id>952D1F1D-C80F-4C12-8AB8-A02FD76BF1C1</gtr:id><gtr:firstName>Nathalie</gtr:firstName><gtr:surname>Juge</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/1551EA57-1B3D-4A9B-A282-1C5A6C3A2FD4"><gtr:id>1551EA57-1B3D-4A9B-A282-1C5A6C3A2FD4</gtr:id><gtr:firstName>Arjan</gtr:firstName><gtr:surname>Narbad</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BBS%2FE%2FF%2F00042572"><gtr:id>C9C964D9-6C12-42F7-ADE3-12CEB0715593</gtr:id><gtr:title>Molecular Targets Open for Regulation by the gut flora New Avenues for improved Diet to Optimize European health (TORNADO)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>BBS/E/F/00042572</gtr:grantReference><gtr:abstractText>Europe is facing major diet related health problems. Attitudes to eating habits have to be changed and the benefits of alternative treatment regimes substantiated. This can only be achieved by providing guidelines regulating health claims based on scientific data. Thus, there is a unique opportunity to use gut flora in potential treatment regimes and as a preventive target for major diet related health problems. TORNADO consortium of which IFR is a partner, proposes a systemic and comprehensive mechanistic approach to deliver scientific data that can be compiled as guidelines for European authorities. TORNADO will determine the influence of diet on the gut flora and highlight the impact of gut flora on the immune system/other organ systems. TORNADO aims to investigate molecular targets that are subject to regulation by gut flora and diet that sustain health. This will be done by an increasing level of specificity, from (1) investigations of dietary habits and health in population cohorts, through (2) intervention studies in humans and animals. TORNADO will deliver data that can be used to recommend biomarkers for evaluating effects of diet or microbes. TORNADO?s program will accelerate future design of personalized functional food for specific target groups.</gtr:abstractText><gtr:fund><gtr:end>2014-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-09-01</gtr:start><gtr:type>EXPENDITURE_PROJECTED</gtr:type><gtr:valuePounds>264100</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Our findings give greater understanding of the role of gut bacteria in health and disease. The findings have been used to inform the academics via science publication and we have disseminated the output to general public via internet web pages and press releases. One of the discoveries made was related to identification of bacteriophages and their endolysin that specifically target the gut pathogen called Clostridium perfringens that causes human food poisoning but is a major cause of necrotic enteritis in poultry birds that results in billion dollar economic loss to the poultry industry worldwide. We have patented this endolysin and are in the process of developing SMART Probiotics that can be given to poultry farms which should reduce the levels of the pathogen in the GI tract of the poultry birds. If this technology works it will have significant impact both for human health as well as animal welfare.</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>B4FE6CB4-C82D-4EAB-9FB2-ED21A0657367</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>54645f2d9e0947.56182240</gtr:outcomeId><gtr:sector>Agriculture, Food and Drink,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The human and animal gastrointestinal (GI) tract contains a diverse array of bacteria with 100 trillion bacteria in the large intestine. These bacteria play a key role in the development of our immune system and brain function as well as in the development of different disorders including diabetes, obesity, and allergy. This project funded by EU is a multidisciplinary project involving more than 20 European partners with the aim of understanding the role of gut bacteria in different disorders. We contributed to this project by analysis of the complex gut microbiota. Our findings indicated the association of specific bacteria with intestinal disorders, identified the importance of host genetics and diet on the composition of the gut bacteria and discovered novel antimicrobial peptides as well as potential biomarkers of intestinal disease.</gtr:description><gtr:exploitationPathways>Our findings can be used to develop gut microbiota based novel medicine and the application of specific diet to modulate the function of the gut microbiota for improved health. The information obtained can be used by pharmaceutical industries to develop microbiota based medicine, and also by food industry in their quest for personalised nutrition. The endolysin discovery will be taken forward for generating advanced probiotics for biocontrol of the pathogen Clostridium perfringens in the animal host.</gtr:exploitationPathways><gtr:id>A3DEC2D9-D804-49B8-A2B8-C9D7DBF3ECDA</gtr:id><gtr:outcomeId>54645e70dfbb60.22054370</gtr:outcomeId><gtr:sectors><gtr:sector>Creative Economy,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.fp7tornado.eu/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>77894E6C-24B2-4C8C-9E0B-43A13F063CB7</gtr:id><gtr:title>Intestinal PPAR? signalling is required for sympathetic nervous system activation in response to caloric restriction.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9a99933d41e07bd802dc6027a100f105"><gtr:id>9a99933d41e07bd802dc6027a100f105</gtr:id><gtr:otherNames>Duszka K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58c7d5ab653025.21299764</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>820831A7-F3EA-4EC4-9432-85352AA192C0</gtr:id><gtr:title>Bidirectional communication between the Aryl hydrocarbon Receptor (AhR) and the microbiome tunes host metabolism.</gtr:title><gtr:parentPublicationTitle>NPJ biofilms and microbiomes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63cd0283ee47453c9c8c6cc2fc282bd5"><gtr:id>63cd0283ee47453c9c8c6cc2fc282bd5</gtr:id><gtr:otherNames>Korecka A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2055-5008</gtr:issn><gtr:outcomeId>58c7fedf8a0208.05660857</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>757B0DBE-84D6-47A8-A90E-B2CC8CA93321</gtr:id><gtr:title>The influence of whole grain products and red meat on intestinal microbiota composition in normal weight adults: a randomized crossover intervention trial.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a34564130b5491ddf263c1bfe04b73d4"><gtr:id>a34564130b5491ddf263c1bfe04b73d4</gtr:id><gtr:otherNames>Foerster J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d05be51a0782.66836712</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BBS/E/F/00042572</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>